KSQ Therapeutics welcomes Dr Pearl Huang and Theo Melas-Kyriazi to its Board of Directors
– USA, MA – KSQ Therapeutics, a biotechnology company using CRISPR technology to enable the company’s powerful discovery engine to achieve higher probabilities of success in drug development, today announced the appointment of Pearl S.…